Related Experiment Video

Updated: Aug 23, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Inhibitors of measles virus

Dale L Barnard1

  • 1Institute for Antiviral Research, Dept. ADVS, Utah State University, Logan, UT, USA. honery@cc.usu.edu

Antiviral Chemistry & Chemotherapy
|July 23, 2004
PubMed

Insights

Measles virus (MV) infections remain a global threat, necessitating new treatments. Current therapies show limited efficacy, driving research for more potent and safer antiviral drugs to complement vaccination efforts.

Area of Science:

  • Virology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Measles virus (MV) infections persist globally, causing significant morbidity and mortality, particularly in regions with inconsistent vaccination coverage.
  • Outbreaks occur even in industrialized nations due to waning immunity and imported cases, highlighting the need for effective treatments beyond vaccines.
  • Existing therapies like ribavirin offer variable efficacy, underscoring the urgent need for novel therapeutic countermeasures against measles.

Purpose of the Study:

  • To review the current landscape of measles virus (MV) therapeutic research.
  • To identify promising drug candidates and highlight challenges in developing new anti-measles treatments.
  • To emphasize the ongoing need for potent and safe drugs to combat MV infections.

Main Methods:

  • Evaluation of various compounds, including nucleoside analogues, brassinosteroids, coumarins, and natural products, for anti-MV activity.
  • In vitro and animal model studies to assess efficacy and toxicity of potential therapeutic agents.
  • Review of clinical trial data for existing measles treatments and investigational drug candidates.

Main Results:

  • Several classes of compounds have been screened, showing potential in preclinical studies.
  • Current clinical treatments, such as ribavirin, exhibit inconsistent effectiveness.
  • Many investigated agents have not progressed to human trials due to toxicity or low potency concerns.

Conclusions:

  • Despite advances, effective and safe treatments for measles virus infections are still lacking.
  • Further research is crucial to develop novel antiviral drugs with improved potency and safety profiles.
  • New therapeutic agents are needed to supplement existing measles vaccination programs and control global outbreaks.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Rescue of Recombinant Newcastle Disease Virus from cDNA10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...